Sarcoma: Soft Tissue, Connective Tissue & Bone Cancers
Adult Soft Tissue Sarcoma Treatment (PDQ®): Treatment - Patient Information [NCI]
There is hope, innovation and support for those diagnosed with sarcomaPatient Care and Treatment:
The U-M Comprehensive Cancer Center offers a Multidisciplinary Sarcoma Clinic, emphasizing our commitment to a team-based approach to care. What this means to our patients is their case will be reviewed by physicians with specialty training in medical oncology, orthopedic oncology, surgical oncology, radiation oncology, tumor imaging and pathology of bone and soft tissue sarcomas.
The Connective Tissue (Sarcoma) Program receives about 250 new cases annually. This volume allows our team to develop well-rounded experience in treating these diseases, which is an advantage considering most community-based practices see fewer than 10 cases a year.
Children and young adults diagnosed with sarcoma receive treatment at C. S. Mott Children's Hospital in the Solid Tumor Oncology Program.
Research and innovation: We offer trials exclusive to our cancer center, as well as those sponsored by the National Cancer Institute. Our program is a founding member of the Sarcoma Alliance for Research through Collaboration, a clinical trials group that is dedicated to advances in sarcoma treatment through research.
Our patients have access to the U-M Comprehensive Cancer Center's Patient/Family Support Services. To fully understand what this means, please take time to visit the For Cancer Center Patients area of this website. We outline the services available to our patients at every point in their care.